Role of dendritic cell phenotype, determinant spreading, and negative costimulatory blockade in dendritic cell-based melanoma immunotherapy.
Ribas A, Glaspy JA, Lee Y, Dissette VB, Seja E, Vu HT, Tchekmedyian NS, Oseguera D, Comin-Anduix B, Wargo JA, Amarnani SN, McBride WH, Economou JS, Butterfield LH.
Ribas A, et al. Among authors: mcbride wh.
J Immunother. 2004 Sep-Oct;27(5):354-67. doi: 10.1097/00002371-200409000-00004.
J Immunother. 2004.
PMID: 15314544
Clinical Trial.